Synthetic biology company launches JV to commercialize gas-to-liquids bioconversion; isobutanol first target
Green Car Congress
MARCH 28, 2014
Synthetic biology company Intrexon Corporation has formed Intrexon Energy Partners (IEP), a joint venture with a group of external investors, to optimize and to scale-up Intrexon’s gas-to-liquids (GTL) bioconversion platform. IEP’s first target product is isobutanol for gasoline blending. Prior to Intrexon, Groban was at LS9.).
Let's personalize your content